Prevalence of Antidepressant Use during Pregnancy in Denmark, a Nation-Wide Cohort Study
Open accessThe DOI matches its Crossref record; 69 of the 70 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
AIM: The aim of this study was to assess the prevalence and patterns of exposure to antidepressants before, during and after pregnancy in a cohort including all pregnant women in Denmark between 1997 and 2010. METHODS: We performed a retrospective cohort study including 912 322 pregnancies. Information was retrieved from the Danish Birth Registry and The Register of Medicinal Product Statistics to identify women redeeming an antidepressant prescription during pregnancy. Exposure periods were based on standard treatment doses and dispensed pack sizes. RESULTS: We identified 19 740 pregnancies exposed to an antidepressant at some point during pregnancy. The rate of exposure increased from 0.2% in 1997 to 3.2% in 2010. We found that the rate of exposure was halved during the first 3 months of pregnancy. In contrast, we describe a clear increase in exposure after pregnancy among pre-delivery treatment-naïve women. CONCLUSIONS: In spite of uncertainty concerning antidepressants' safety during pregnancy we find a 16-fold increase in exposure rates between 1997 and 2010. The rates describe a sharp decrease in exposure during pregnancy that is probably caused by physicians' hesitation to prescribe antidepressants and women's fear of unwanted effects on the unborn child. More studies are needed to clarify the consequences of antidepressant discontinuation during pregnancy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., Rush, A. J., Walters, E. E., & Wang, P. S. (2003) · JAMA · doi:10.1001/jama.289.23.3095 · Cited by 7,988 · cited 1×
“It is estimated that approximately 20% of women of childbearing age (25–45 years), [1,2] and up to 15% of pregnant women suffer from depressive symptoms [3,4].”
Background(2016) · Repository@Hull (Worktribe) (University of Hull) · doi:10.1111/j.1365 · Cited by 5,304
The Danish Civil Registration System
Pedersen, C. B. (2011) · Scandinavian Journal of Public Health · doi:10.1177/1403494810387965 · Cited by 4,632
The Danish National Hospital Register. A valuable source of data for modern health sciences.
Andersen, T. F., Madsen, M., Jørgensen, J. O. L., Mellemkjoer, L., & Olsen, J. H. (1999) · PubMed · Cited by 2,026
Prevalence of Depression During Pregnancy: Systematic Review
Bennett, H. A., Einarson, A., Taddio, A., Koren, G., & Einarson, T. R. (2004) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000116689.75396.5f · Cited by 1,725 · cited 1×
“It is estimated that approximately 20% of women of childbearing age (25–45 years), [1,2] and up to 15% of pregnant women suffer from depressive symptoms [3,4].”
BackgroundThe Danish Civil Registration System. A cohort of eight million persons.
Pedersen, C. B., Gøtzsche, H., Møller, J. O., & Mortensen, P. B. (2006) · PubMed · Cited by 1,617
Offspring of Depressed Parents: 20 Years Later
Weissman, M. M., Wickramaratne, P., Nomura, Y., Warner, V., Pilowsky, D., & Verdeli, H. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.6.1001 · Cited by 1,059
Cohen, L. S. (2006) · JAMA · doi:10.1001/jama.295.5.499 · Cited by 1,031
The Danish prescription registries.
Gaist, D., Sørensen, H. T., & Hallas, J. (1997) · PubMed · Cited by 570
Women’s Attitudes, Preferences, and Perceived Barriers to Treatment for Perinatal Depression
Goodman, J. H. (2009) · Birth · doi:10.1111/j.1523-536x.2008.00296.x · Cited by 526 · cited 1×
“On the other hand, in spite of doctor recommendation, only 35% of pregnant women reported to be willing to take antidepressants during pregnancy in an American study [52].”
Background
Cited by
Clinical management of perinatal anxiety disorders: A systematic review
Marchesi, C., Ossola, P., Amerio, A., Daniel, B. D., Tonna, M., & De Panfilis, C. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.11.004 · Cited by 169
O'Connor, T. G., Monk, C., & Fitelson, E. M. (2014) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12153 · Cited by 130
“…maternal anxiety, stress, and depression is particularly problematic given resistance to medication in certain subgroups in particular (see, Jimenez-Solem et al., 2013; Kozhimannil, Adams, Soumerai, Busch, & Huskamp, 2011) and the suggestion that SSRIs may have adverse effects on the…”
BackgroundGao, S.-Y., Wu, Q.-J., Sun, C., Zhang, T.-N., Shen, Z.-Q., Liu, C.-X., Gong, T.-T., Xu, X., Ji, C., Huang, D.-H., et al. (2018) · BMC Medicine · doi:10.1186/s12916-018-1193-5 · Cited by 152
Zoega, H., Kieler, H., Nørgaard, M., Furu, K., Valdimarsdottir, U., Brandt, L., & Haglund, B. (2015) · PLOS ONE · doi:10.1371/journal.pone.0144474 · Cited by 108
“Many, but not all [3], previous studies of the utilization and discontinuation of these antidepressants during pregnancy are based on self-reported surveys [4, 23, 24], insurance or reimbursement data [7, 6, 8, 17], or local pharmacy-dispensing data [25], potentially limiting the internal and external validity of the…”
BackgroundResultInfluentialPerinatal psychiatric episodes: a population-based study on treatment incidence and prevalence
Munk-Olsen, T., Maegbaek, M. L., Johannsen, B. M., Liu, X., Howard, L. M., di Florio, A., Bergink, V, & Meltzer-Brody, S. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.190 · Cited by 103
Mezzacappa, A., Lasica, P.-A., Gianfagna, F., Cazas, O., Hardy, P., Falissard, B., Sutter-Dallay, A.-L., & Gressier, F. (2017) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2017.0124 · Cited by 108
Bais, B., Molenaar, N. M., Bijma, H. H., Hoogendijk, W. J. G., Mulder, C. L., Luik, A. I., den Berg, M. P. L., & Kamperman, A. M. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.03.014 · Cited by 107
“This decrease in the postpartum period differs from the prevalence of other psychotropic medication, such as antidepressant medication, where prevalence generally increases from pregnancy to the postpartum period (Andrade et al., 2016; Cooper et al., 2007; Jimenez-Solem et al., 2013; Molenaar et al., 2019).”
BackgroundSertraline use during pregnancy and the risk of major malformations
Bérard, A., Zhao, J., & Sheehy, O. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.01.034 · Cited by 94
Liu, X., Agerbo, E., Ingstrup, K. G., Musliner, K., Meltzer-Brody, S., Bergink, V., & Munk-Olsen, T. (2017) · BMJ · doi:10.1136/bmj.j3668 · Cited by 90
SSRI and SNRI use during pregnancy and the risk of persistent pulmonary hypertension of the newborn
Bérard, A., Sheehy, O., Zhao, J., Vinet, É., Bernatsky, S., & Abrahamowicz, M. (2017) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13194 · Cited by 85
Exposure to Selective Serotonin Reuptake Inhibitors in Early Pregnancy and the Risk of Miscarriage
Andersen, J. T., Andersen, N. L., Horwitz, H., Poulsen, H. E., & Jimenez‐Solem, E. (2014) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000000447 · Cited by 81
Self-citationGalbally, M., van IJzendoorn, M. H., Permezel, M., Saffery, R., Lappas, M., Ryan, J. L., van Rossum, E. F. C., Johnson, A. R., Teti, D. M., & Lewis, A. J. (2017) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.1558 · Cited by 78
“In many countries, one of the most cost effective and widely available treatment options for depression is antidepressant medication and their use in pregnancy is on the rise (Andrade et al., 2008; Jimenez‐Solem et al., 2013; Oberlander, Warburton, Misri, Aghajanian, & Hertzman, 2006).”
BackgroundGalbally, M., van Rossum, E. F. C., Watson, S., de Kloet, E. R., & Lewis, A. J. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2019.104374 · Cited by 76
“use of antidepressants to treat depression and anxiety in pregnancy [19].”
MethodRommel, A., Bergink, V., Liu, X., Munk‐Olsen, T., & Molenaar, N. M. (2020) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.19r12965 · Cited by 72
Antipsychotic drug use in pregnancy: A multinational study from ten countries
Reutfors, J., Cesta, C. E., Cohen, J. M., Bateman, B. T., Brauer, R., Einarsdóttir, K., Engeland, A., Furu, K., Gissler, M., Havard, A., et al. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.03.048 · Cited by 70
Forsberg, L., Navér, L., Gustafsson, L. L., & Wide, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111327 · Cited by 69
Glover, M. E., Pugh, P. C., Jackson, N., Cohen, J. L., Fant, A. D., Akil, H., & Clinton, S. M. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.10.044 · Cited by 65
“Sertraline, one of the most commonly prescribed SSRIs in pregnant women (Wichman et al., 2009, Alwan et al., 2011, Jimenez-Solem et al., 2013), inhibits several complexes in oxidative phosphorylation within isolated mitochondria, and causes cellular ATP depletion in primary rat hepatocytes (Li et…”
BackgroundVries, C. D., Gadzhanova, S., Sykes, M. J., Ward, M., & Roughead, E. E. (2020) · Drug Safety · doi:10.1007/s40264-020-01027-x · Cited by 63
Bellantuono, C., Vargas, M., Mandarelli, G., Nardi, B., & Martini, M. G. (2015) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.2473 · Cited by 55
“Among ADs, selective serotonin reuptake inhibitors (SSRIs) have been the most frequently prescribed drugs during pregnancy in the last decade (Jimenez-Solem et al. 2013).”
BackgroundSujan, A. C., Öberg, A. S., Quinn, P. D., & D'Onofrio, B. M. (2019) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.13004 · Cited by 52
“…problems; autism spectrum disorder; attention-deficit/hyperactivity disorder; causal inference Introduction Antidepressant use, particularly use of selective serotonin reuptake inhibitors (SSRIs), among pregnant women is common and increasing (Andrade et al., 2016; Jimenez-Solem et al., 2013).”
Patterns of antidepressant use during pregnancy: a nationwide population‐based cohort study
Bénard‐Laribière, A., Pambrun, É., Sutter‐Dallay, A., Gautier, S., Hurault‐Delarue, C., Damase‐Michel, C., Lacroix, I., Bégaud, B., & Pariente, A. (2018) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13608 · Cited by 54
Shen, Z., Gao, S., Li, S. X., Zhang, T., Liu, C., Lv, H., Zhang, Y., Gong, T., Xu, X., Ji, C., et al. (2017) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13161 · Cited by 48
Exposure to Selective Serotonin Reuptake Inhibitors in Early Pregnancy and the Risk of Miscarriage
Yuen, S., Rezai, S., & Henderson, C. E. (2015) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000000656 · Cited by 53
Johansen, R. L. R., Mortensen, L. H., Andersen, A. N., Hansen, A. V., & Strandberg‐Larsen, K. (2014) · Paediatric and Perinatal Epidemiology · doi:10.1111/ppe.12160 · Cited by 51
Grzeskowiak, L. E., Morrison, J. L., Henriksen, T. B., Bech, B. H., Obel, C., Olsen, J., & Pedersen, L. (2015) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.13611 · Cited by 50
Grzeskowiak, L. E., McBain, R. D., Dekker, G., & Clifton, V. L. (2015) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.13612 · Cited by 48
Ramsteijn, A. S., de Wijer, L. V., Rando, J., van Luijk, J. A. K. R., Homberg, J. R., & Olivier, J. D. A. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.04.010 · Cited by 46
Sharma, G. V., Gaffey, A. E., Hameed, A., Kasparian, N. A., Mauricio, R., Marsh, E. B., Beck, D., Skowronski, J. N., Wolfe, D. S., & Levine, G. N. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.125.041369 · Cited by 42
Broeks, S. C., Horsdal, H. T., Ingstrup, K. G., & Gasse, C. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.12.001 · Cited by 41
Hjorth, S., Bromley, R., Ystrøm, E., Lupattelli, A., Spigset, O., & Nordeng, H. (2019) · PLoS ONE · doi:10.1371/journal.pone.0219778 · Cited by 44
“Funding: This work was supported by the European Research Council Starting Grant “DrugsInPregnancy” [grant number 639377 to SH] and The PharmaTox Strategic Research Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway.”
BackgroundDiagnosing and Treating Depression During Pregnancy
Wichman, C. L., & Stern, T. A. (2015) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.15f01776 · Cited by 41
Halvorsen, A., Hesel, B., Østergaard, S. D., & Danielsen, A. A. (2019) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13030 · Cited by 35
“Indeed, the use of SSRIs during pregnancy is quite prevalent—as approximately 3% of pregnant women in Denmark (in the year of 2009) and 6% of pregnant women in the United States (in the year of 2006) used an SSRI during pregnancy (9, 10).”
BackgroundLaurent, L., Huang, C., Ernest, S. R., Bérard, A., Vaillancourt, C., & Hales, B. F. (2016) · Birth Defects Research Part A Clinical and Molecular Teratology · doi:10.1002/bdra.23537 · Cited by 34
Prenatal Antidepressant Exposure and Child Motor Development: A Meta-analysis
Grove, K., Lewis, A. J., & Galbally, M. (2018) · PEDIATRICS · doi:10.1542/peds.2018-0356 · Cited by 34
“Inclusion and Exclusion Criteria Researchers’ studies were included in the systematic review if they (1) reported primary data, (2) were published in the English language, (3) were studies involving humans, (4) used and described an accepted measure of motor performance, and (5) reported on infant or child motor devel…”
BackgroundSun, Y., Dreier, J. W., Liu, X., Ingstrup, K. G., Mægbæk, M. L., Munk‐Olsen, T., & Christensen, J. (2019) · Brain and Behavior · doi:10.1002/brb3.1441 · Cited by 33
Suarez, E. A., Landi, S. N., Conover, M. M., & Funk, M. J. (2018) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4387 · Cited by 32
Galbally, M., Watson, S., Permezel, M., & Lewis, A. J. (2018) · Psychological Medicine · doi:10.1017/s0033291718002040 · Cited by 32
“Our study builds on this with data to understand differences in effect on sexual functioning specifically in the perinatal period and provides reassurance for women who do require ongoing treatment for depression during the perinatal period (Cooper et al., 2007; Bakker et al., 2008; Jimenez-Solem et al., 2013).”
BackgroundKhalifeh, H., Molyneaux, E., Brauer, R., Vigod, S. N., & Howard, L. M. (2019) · BJGP Open · doi:10.3399/bjgpopen19x101666 · Cited by 33
Ankarfeldt, M. Z., Petersen, J., Andersen, J. T., Li, H., Motsko, S. P., Fast, T., Hede, S. M., & Jimenez‐Solem, E. (2021) · PLoS Medicine · doi:10.1371/journal.pmed.1003851 · Cited by 32
Self-citationMolenaar, N. M., Lambregtse-van den Berg, M. P., & Bonsel, G. J. (2020) · Archives of Women's Mental Health · doi:10.1007/s00737-019-0951-5 · Cited by 30
Child developmental outcomes in preschool children following antidepressant exposure in pregnancy
Galbally, M., Lewis, A. J., & Buist, A. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415569800 · Cited by 30
Galbally, M., Ryan, J. L., van IJzendoorn, M. H., Watson, S., Spigset, O., Lappas, M., Saffery, R., de Kloet, E. R., & Lewis, A. J. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.01.004 · Cited by 29
Kittel‐Schneider, S., Felice, E., Buhagiar, R., den Berg, M. P. L., Wilson, C. A., Banjac, V., Vujović, K. S., Medić, B., Opanković, A., Fonseca, A., et al. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19041973 · Cited by 28
“1 [18,19] Citalopram, sertraline, fluoxetine [19] NS BZD: 0.”
Unroe, K. A., Glover, M. E., Shupe, E. A., Feng, N., & Clinton, S. M. (2021) · Neuroscience · doi:10.1016/j.neuroscience.2021.07.007 · Cited by 27
Antidepressant Use During Pregnancy and Asthma in the Offspring
Liu, X., Olsen, J., Pedersen, L. H., Agerbo, E., Yuan, W., & Li, J. (2015) · PEDIATRICS · doi:10.1542/peds.2014-4073 · Cited by 25
Bais, B., Kamperman, A. M., Bijma, H. H., Hoogendijk, W. J., Souman, J. L., Knijff, E., & Lambregtse-van den Berg, M. P. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-038030 · Cited by 24
Kühn, M., Metsä‐Simola, N., & Martikainen, P. (2022) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-022-02371-2 · Cited by 24
“This pattern was also reported in a previous study, which found that antidepressant use halved during the first three months of pregnancy, and then increased after pregnancy [53].”
ResultTrajectories of antidepressant drugs during pregnancy: A cohort study from a community‐based sample
Cabaillot, A., Bourset, A. C., Mulliez, A., Delorme, J., Orri, M., Vicard‐Olagne, M., Zénut, M., Tournier, M., Gallot, D., Authier, N., et al. (2020) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14449 · Cited by 23
Prenatal antidepressant exposure and emotional disorders until age 22: a danish register study
Bliddal, M., Wesselhoeft, R. T., Strandberg‐Larsen, K., Ernst, M. T., Weissman, M. M., Gingrich, J. A., Talati, A., & Pottegård, A. (2023) · Child and Adolescent Psychiatry and Mental Health · doi:10.1186/s13034-023-00624-9 · Cited by 23
“…[2] that this association is found in both female and male children (Table S5); [3] that it is observed in each trimester of use (Table S10) and [4] that the risk of the primary outcome is greater in children who were exposed to SSRIs in utero than those who whose mothers had previously used an…”
BackgroundInfluentialVuong, H. E., Coley, E. J. L., Kazantsev, M., Cooke, M. E., Rendon, T. K., Paramo, J., & Hsiao, E. Y. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113353 · Cited by 22
Brumbaugh, J. E., Ball, C. T., Crook, J. E., Stoppel, C. J., Carey, W. A., & Bobo, W. V. (2023) · Mayo Clinic Proceedings Innovations Quality & Outcomes · doi:10.1016/j.mayocpiqo.2023.02.002 · Cited by 21
Askaa, B., Jimenez‐Solem, E., Poulsen, H. E., & Andersen, J. T. (2014) · Obstetrics and Gynecology International · doi:10.1155/2014/945621 · Cited by 20
Self-citationKieler, H., Malm, H. T., Artama, M., Engeland, A., Furu, K., Gissler, M., Nørgaard, M., Stephansson, O., Valdimarsdóttir, U. A., Zoëga, H., et al. (2014) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.13164 · Cited by 20
Prenatal exposure to antidepressants and risk of epilepsy in childhood
Mao, Y., Pedersen, L. H., Christensen, J., Vestergaard, M., Zhou, W., Olsen, J., & Sun, Y. (2016) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4072 · Cited by 19
“maternal depression, we categorized children into three groups according to a diagnosis of depression in their mothers: (1) the mother had a registry-based hospital diagnosis of depression during the pregnancy or within 6months prior to pregnancy, (2) the mother had a hospital diagnosis of depression more than 6months…”
MethodTreating Anxiety During Pregnancy: Patient Concerns About Pharmaceutical Treatment
Lemon, E. L., Vanderkruik, R. C., Arch, J. J., & Dimidjian, S. (2020) · Maternal and Child Health Journal · doi:10.1007/s10995-019-02873-7 · Cited by 19
Goisis, A., Palma, M. I., Metsä‐Simola, N., Klemetti, R., Martikainen, P., Myrskylä, M., Pelikh, A., Tosi, M., & Remes, H. M. (2022) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2022.10.041 · Cited by 19
Bérard, A., Levin, M. G., Sadler, T. W., & Healy, D. T. (2018) · Bioelectricity · doi:10.1089/bioe.2018.0003 · Cited by 18
No association between prenatal exposure to psychotropics and intelligence at age five
Eriksen, H. F., Kesmodel, U. S., Pedersen, L. H., & Mortensen, E. L. (2015) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.12611 · Cited by 18
“2% of pregnant women in Denmark (2) and by an even higher proportion in the USA (3).”
BackgroundInfluentialNielsen, S. W., Ljungdalh, P. S., Nielsen, J., Nørgård, B. M., & Qvist, N. (2017) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-017-0667-4 · Cited by 16
Antidepressant dispensing before, during, and after pregnancy in New Zealand, 2005‒2014
Donald, S., SHARPLES, K. J., Barson, D., Horsburgh, S., & Parkin, L. (2021) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.13352 · Cited by 15
Sánchez, N., Juárez-Balarezo, J., Olhaberry, M., Oneto, H. G., Muzard, A., Mardonez, M. J., Franco, P., Barrera, F., & Gaete, M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.632766 · Cited by 15
“…development is produced by the embryo, as early as the two-cell stage (Amireault and Dube, 2005; Dube and Amireault, 2007; Kaihola et al., 2016), and from a source supplied by the maternal blood (Cote et al., 2007) and trophoblast placental cells (Bonnin and Levitt, 2011; Kaihola et al., 2015).”
BackgroundAnkarfeldt, M. Z., Petersen, J., Andersen, J. T., Fernandes, M. F. S., Li, H., Motsko, S. P., Fast, T., & Jimenez‐Solem, E. (2021) · Drugs - Real World Outcomes · doi:10.1007/s40801-021-00252-9 · Cited by 15
“The most common antidepressants are selective serotonin reuptake inhibitors (SSRIs) [9–12] and the second most common are serotonin and norepinephrine reuptake inhibitors (SNRIs), including duloxetine and venlafaxine [9, 10, 13].”
BackgroundSelf-citationEaster, A., Hopper, H., Howard, L. M., & Miele, M. (2020) · Springer eBooks · doi:10.1007/978-3-030-31753-9_9 · Cited by 15
Gardner, R. M., Sultan, P., Bernert, R. A., & Simard, J. F. (2025) · PLoS ONE · doi:10.1371/journal.pone.0322536 · Cited by 14
“These antidepressants were chosen based on previous publications in perinatal depression [23,24].”
Anzai, T., Takahashi, K., Watanabe, M., Mochizuki, M., & Murashima, A. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-02525-z · Cited by 13
Molenaar, N. M., Brouwer, M. E., Kamperman, A. M., Burger, H., Williams, A. D., Hoogendijk, W. J. G., Bockting, C., & den Berg, M. P. L. (2019) · PLoS ONE · doi:10.1371/journal.pone.0212964 · Cited by 12
The risks associated with prenatal antidepressant exposure: time for a precision medicine approach
Pedersen, L. H. (2017) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2017.1341872 · Cited by 12
Ankarfeldt, M. Z., Petersen, J., Andersen, J. T., Fernandes, M. F. S., Li, H., Motsko, S. P., Fast, T., & Jimenez‐Solem, E. (2022) · Drugs - Real World Outcomes · doi:10.1007/s40801-022-00334-2 · Cited by 11
“In Denmark, the most commonly used antidepressants include selective serotonin reuptake inhibitors (SSRIs) [8], followed by serotonin and norepinephrine reuptake inhibitors (SNRIs) [7, 8], reflecting that SSRIs are first-line treatment according to national guidelines, with SNRIs being second-line treatment.”
BackgroundSelf-citationUse of stimulants, over‐the‐counter and prescription drugs among Danish pregnant women
Volqvartz, T., Vestergaard, A. L., Aagaard, S. K., Andreasen, M. F., Lesnikova, I., Uldbjerg, N., Larsen, A., & Bor, P. (2020) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13396 · Cited by 11
Kapra, O., Rotem, R. S., & Gross, R. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.555740 · Cited by 11
“Confining the analysis only to children born to mothers with a history of psychiatric disorders indeed seems to attenuate or nullify the SSRI-ASD association (3), as observed in one systematic review (46) and one meta-analysis (39) (respectively: pooled adjusted risk ratio= 1.”
BackgroundPrenatal Antidepressant Exposure and Childhood Autism Spectrum Disorders: Cause for Concern?
Pedersen, L. H. (2015) · Pediatric Drugs · doi:10.1007/s40272-015-0141-5 · Cited by 11
“For an exposure [3] and an outcome [24] with significant changes over time, the calendar time bias might be particularly problematic.”
BackgroundNygaard, L., Rossen, C. B., & Buus, N. (2015) · Issues in Mental Health Nursing · doi:10.3109/01612840.2015.1004605 · Cited by 11
“The same tendency was also observed in Denmark, where the prevalence of prescribed antidepressants to pregnant women increased to 3.2% in 2010 from 0.2% in 1997 (Jimenez-Solem et al., 2013).”
ResultInfluentialMatsumoto, A. K., Higashi, C. M., Bonifácio, K. L., Barbosa, M. A., Klein, R. M., Filgueiras, G. B., Ceravolo, G. S., & Moreira, E. G. (2016) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2016.05.006 · Cited by 11
Chronic use of psychotropic medications in breastfeeding women: Is it safe?
Kronenfeld, N., Baran, T. Z., Berlin, M., Karra, N., Dinavitser, N., Cohen, R., Wiener, Y., Schwartzberg, E., & Bercovitch, M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0197196 · Cited by 11
Ramsteijn, A. S., Verkaik‐Schakel, R. N., Houwing, D. J., Plösch, T., & Olivier, J. D. A. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-022-01270-z · Cited by 10
Siracusano, M., Riccioni, A., Gialloreti, L. E., Carloni, E., Baratta, A., Ferrara, M., Arturi, L., Lisi, G., Adulti, I., Rossi, R., et al. (2021) · Children · doi:10.3390/children8121150 · Cited by 9
A closer look at the preventative effect of antidepressants in postpartum depression
Sharma, V. (2017) · Archives of Women s Mental Health · doi:10.1007/s00737-016-0709-2 · Cited by 9
Grzeskowiak, L. E., Leggett, C., Costi, L., Roberts, C. T., & Amir, L. H. (2018) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13575 · Cited by 9
Kelty, E. A., Cumming, C., & Preen, D. B. (2022) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2678 · Cited by 8
Spildrejorde, M., Leithaug, M., SAMARA, A. A., Aass, H. C. D., Sharma, A., Acharya, G., Nordeng, H., Gervin, K., & Lyle, R. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1428538 · Cited by 7
Sertraline use during pregnancy and effect on fetal cardiac function
Kolding, L., Pedersen, L. H., Petersen, O. B., Uldbjerg, N., & Sandager, P. (2019) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2019.1688297 · Cited by 7
“It is therefore a potential matter of concern that 3–8% of all pregnant women use selective serotonin reuptake inhibitors (SSRIs), which may increase the risk of fetal heart malformations [7,8].”
BackgroundLeung, M. T. Y., Wong, K. H. T. W., Ho, P. W. H., Ip, P., Wei, L., Wong, I. C. K., & Man, K. K. C. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.09.040 · Cited by 7
Staal, L., Plösch, T., Kallak, T. K., Poromaa, I. S., Wertheim, B., & Olivier, J. D. A. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00621 · Cited by 6
Güngör, B. B., Öztürk, N., Atar, A. Ö., & Aydın, N. (2019) · Psychiatry and Clinical Psychopharmacology · doi:10.1080/24750573.2019.1673936 · Cited by 6
“The studies also revealed an increase in the prevalence of antidepressant exposure from 0.2% to 3.2% between 1997 and 2010 in Denmark [4] and from 0.8% to 2.1% between 1999 and 2014 in the Netherlands [5].”
BackgroundInfluentialMoreira, S. D. S., Manoel, B. D. M., Inácio, J. P. G., de Souza, C. G., Reis, A. C. C., Jorge, B. C., de Aquino, A. M., Scarano, W. R., Cardoso, C. A. L., & Arena, A. C. (2022) · Journal of Applied Toxicology · doi:10.1002/jat.4389 · Cited by 6
“Venlafaxine (VEN), a serotonin-norepinephrine reuptake inhibitor (SNRI), has been considered one of the main options for the treatment of maternal depression/anxiety disorders (Huybrechts et al., 2013; Jimenez-Solem et al., 2013; Sun et al., 2019).”
BackgroundLiving with uncertainty: antidepressants and pregnancy
Jones, I. R., & McDonald, L. (2014) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.113.141713 · Cited by 6
Antidepressant use during pregnancy and risk of congenital heart defects: A case‐time‐control study
Sun, Y., Pedersen, L. H., Wu, C. S., Petersen, I., Sørensen, H. T., & Olsen, J. (2019) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4844 · Cited by 6
“5% of children have been exposed to maternal ADs during pregnancy, which was quite consistent with the findings for children born at that period from the register‐based study.(48,49) The case‐time‐control study may be more sensitive to misclassification of both exposure and outcome.”
ResultAdministration of electroconvulsive therapy for major depression during pregnancy: a case report
Erturk, A., Aktöz, F., Örgül, G., Mutlu, E., Demir, B., & Tuncer, Z. S. (2019) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2019.1628727 · Cited by 4
“https://doi.org/10.1080/01443615.2019.1628727 during pregnancy (Jimenez-Solem et al. 2013).”
InfluentialUnroe, K. A., Maltman, J. L., Shupe, E. A., & Clinton, S. M. (2022) · Developmental Psychobiology · doi:10.1002/dev.22292 · Cited by 4
Epidemiology of the Use of Psychotropic Drugs in Pregnant and Nursing Women
Alwan, S. S., & Bérard, A. (2019) · Springer eBooks · doi:10.1007/978-3-319-92919-4_1 · Cited by 4
Barbosa, M. A., Veríssimo, L. F., Gerardin, D. C. C., Pelosi, G. G., Ceravolo, G. S., & Moreira, E. G. (2019) · Reproduction Fertility and Development · doi:10.1071/rd18279 · Cited by 4
Makovec, T. (2020) · International Journal of Risk & Safety in Medicine · doi:10.3233/jrs-190049 · Cited by 4
“As study from Nordic countries suggests that approximately 2–8% of pregnant women receive antide-pressants [37] and its use has been constantly rising in the last few decades [38].”
Hippman, C., Balneaves, L. G., Ryan, D. M., & Austin, J. (2023) · Women s Reproductive Health · doi:10.1080/23293691.2023.2230463 · Cited by 3
Larcin, L., Ngwasiri, C. A., Neven, A., Damase‐Michel, C., & Kirakoya‐Samadoulougou, F. (2024) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.70021 · Cited by 3
“In Denmark, pregnant women with exposure to antidepressants during pregnancy, on average, had a lower household income and a lower educational level than unexposed pregnant women [25].”
InfluentialGranström, A. L., Skoglund, C. B., & Wester, T. (2019) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2019.02.015 · Cited by 3
Pharmacological Management of Major Depression in Pregnancy
Boyce, P. M., Galbally, M., Snellen, M., & Buist, A. (2014) · Springer eBooks · doi:10.1007/978-3-642-54562-7_6 · Cited by 2
Kelada, M. N. B., Metwaly, E. S., Safwat, M., & Mottelib, L. M. M. A. A. E. (2019) · The Egyptian Journal of Histology · doi:10.21608/ejh.2019.15379.1150 · Cited by 2
“Studies revealed that it is marvelously increasing; for example 3-folds in the United States from 1998 to 2005[7], and 16fold in Europe from 1997 to 2010[8].”
BackgroundPsychotropic Drugs in Pregnancy and Breastfeeding
Orsolini, L., & Bellantuono, C. (2022) · Springer eBooks · doi:10.1007/978-3-030-91832-3_16 · Cited by 2
Jones, S. (2019) · Scholars Archive - University at Albany (University at Albany, State University of New York) · doi:10.54014/nvz8-07kv · Cited by 2
Metadata
- Authors
- Jimenez-Solem, E., Andersen, J. T., Petersen, M., Broedbaek, K., Andersen, N. L., Torp-Pedersen, C., & Poulsen, H. E.
- Affiliations
- Bispebjerg Hospital (DK)
- Copenhagen University Hospital (DK)
- University of Copenhagen (DK)
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-04-25
- Volume
- 8
- Issue
- 4
- Pages
- e63034
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3636192
- OpenAlex
- W2158461066
- Cited by
- 119
- References
- 68
- Citations by year
- 2026: 1 · 2025: 7 · 2024: 4 · 2023: 7 · 2022: 9 · 2021: 8 · 2020: 15 · 2019: 16 · 2018: 11 · 2017: 7 · 2016: 9 · 2015: 14 · 2014: 10 · 2013: 1
- FWCI
- 11.56
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Forsknings- og Innovationsstyrelsen
- Danish Agency for Science and Higher Education
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
- Keywords
- antidepressants, pregnancy, antidepressant exposure, prevalence, maternal mental health, antidepressant discontinuation, postpartum depression, prescribing patterns, drug safety in pregnancy, Denmark
- MeSH terms
- Adult, Antidepressive Agents, Denmark, Female, Humans, Pregnancy, Public Health, Time Factors, Cohort Studies, Prevalence, Maternal Exposure, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.